Regulatory Updates
🇪🇺 EMA Page 11EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 121–132 of 171 articles
CHMP Meeting Highlights: Drug Approvals from May 2026
EU Lawmakers Reach Provisional Deal on Critical Medicines Act: Market Analysis
EFPIA Warns of Widening Access Gap Under US Pricing Reforms
European Biotechs Innovate in Cell and Gene Therapy Manufacturing
MHRA Consultation on Rare Disease Therapy Draft Guidance
Roche's Elevidys: A New Hope for DMD Gene Therapy Approval
First GLP-1 Gene Therapy Clinical Trial Approved in Europe
MaaT Pharma's Regulatory Update on MaaT013 (Xervyteg®)
February Batch of Novel Medicines Recommended for Approval by EMA/CHMP
AstraZeneca's FDA Approval: Implications for Hypertension and Fasenra
Global Pharmacovigilance Reporting: A Comparative Analysis
CMA Deal Strengthens EU Medicine Supply Chains